Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes
While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation syst...
Gespeichert in:
Veröffentlicht in: | Proceedings of the National Academy of Sciences - PNAS 1992-12, Vol.89 (23), p.11199-11203 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 11203 |
---|---|
container_issue | 23 |
container_start_page | 11199 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 89 |
creator | von Hofe, Eric Fairbairn, Leslie Margison, Geoffrey P. |
description | While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG. |
doi_str_mv | 10.1073/pnas.89.23.11199 |
format | Article |
fullrecord | <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_jstor_primary_2360674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>2360674</jstor_id><sourcerecordid>2360674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3439-b1c6209c271ea9161ffae5317d3dd6b8a0b7072cc61f5f7ba4ee990be29db4653</originalsourceid><addsrcrecordid>eNp9UctuEzEUHSFQCYU9CxBeIJUFTvyYRyyxSUNpK7WphMLa8njuJC6OHY09JflZvoWZJAQqJFZ-nNfVPUnympIhJQUfrZ0Kw7EYMj6klArxJBlQIijOU0GeJgNCWIHHKUufJy9CuCeEiGxMTpITmmZpIcQg-fkVrIrGu7A0a3QO8QeAQ3c5ntjvW7tolTMO8OfZBO0-YqNcqKFRAdBER_Ng4hYpV6EZvoW43Fo8O8MzExuPZ_sz-J1J1dtcu6rVUKHbNu4yP6L5zs83q8O7t5puo49-Y3TvbRya8qsRJXM6YmgK1gZ0sVk3EIJxi-7qF-B8G_4d7xIchJfJs1rZAK8O52ny7cvFfHqFb-4ur6eTG6x5ygUuqc4ZEZoVFJSgOa1rBRmnRcWrKi_HipQFKZjWHZLVRalSACFICUxUZZpn_DT5tPddt-UKKg2uG8XKdWNWqtlKr4x8jDizlAv_IDOS0aKTk71cdwsLDdRHJSWyL1r2RcuxkIzLXdGd5O3fiX8E-2Y7_P0BV0ErW3eb0SYcaWnGRJbnHe3dgdYH_EYfB334P0PWrbURNrGjvtlT70P0zZHLeE7yIuW_APZs2WQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>von Hofe, Eric ; Fairbairn, Leslie ; Margison, Geoffrey P.</creator><creatorcontrib>von Hofe, Eric ; Fairbairn, Leslie ; Margison, Geoffrey P.</creatorcontrib><description>While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.89.23.11199</identifier><identifier>PMID: 1454799</identifier><identifier>CODEN: PNASA6</identifier><language>eng</language><publisher>Washington, DC: National Academy of Sciences of the United States of America</publisher><subject>Animals ; Biological and medical sciences ; Carcinogenesis ; Carcinogenesis, carcinogens and anticarcinogens ; Cell culture techniques ; Cell Cycle ; Cell lines ; Cell Survival - drug effects ; Cell Transformation, Neoplastic - drug effects ; Cells ; Cells, Cultured ; Chemical agents ; Cytotoxicity ; DNA Damage ; DNA Repair ; Doubling time ; Genes ; Genetic mutation ; In Vitro Techniques ; Lesions ; Medical sciences ; Methylnitronitrosoguanidine - pharmacology ; Methyltransferases - genetics ; Methyltransferases - metabolism ; Mice ; Mutagenesis ; O-Methylguanine-DNA Methyltransferase ; Transfection ; Tumors</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11199-11203</ispartof><rights>Copyright 1992 The National Academy of Sciences of the United States of America</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3439-b1c6209c271ea9161ffae5317d3dd6b8a0b7072cc61f5f7ba4ee990be29db4653</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/89/23.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/2360674$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/2360674$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4529566$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1454799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>von Hofe, Eric</creatorcontrib><creatorcontrib>Fairbairn, Leslie</creatorcontrib><creatorcontrib>Margison, Geoffrey P.</creatorcontrib><title>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Cell culture techniques</subject><subject>Cell Cycle</subject><subject>Cell lines</subject><subject>Cell Survival - drug effects</subject><subject>Cell Transformation, Neoplastic - drug effects</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Chemical agents</subject><subject>Cytotoxicity</subject><subject>DNA Damage</subject><subject>DNA Repair</subject><subject>Doubling time</subject><subject>Genes</subject><subject>Genetic mutation</subject><subject>In Vitro Techniques</subject><subject>Lesions</subject><subject>Medical sciences</subject><subject>Methylnitronitrosoguanidine - pharmacology</subject><subject>Methyltransferases - genetics</subject><subject>Methyltransferases - metabolism</subject><subject>Mice</subject><subject>Mutagenesis</subject><subject>O-Methylguanine-DNA Methyltransferase</subject><subject>Transfection</subject><subject>Tumors</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctuEzEUHSFQCYU9CxBeIJUFTvyYRyyxSUNpK7WphMLa8njuJC6OHY09JflZvoWZJAQqJFZ-nNfVPUnympIhJQUfrZ0Kw7EYMj6klArxJBlQIijOU0GeJgNCWIHHKUufJy9CuCeEiGxMTpITmmZpIcQg-fkVrIrGu7A0a3QO8QeAQ3c5ntjvW7tolTMO8OfZBO0-YqNcqKFRAdBER_Ng4hYpV6EZvoW43Fo8O8MzExuPZ_sz-J1J1dtcu6rVUKHbNu4yP6L5zs83q8O7t5puo49-Y3TvbRya8qsRJXM6YmgK1gZ0sVk3EIJxi-7qF-B8G_4d7xIchJfJs1rZAK8O52ny7cvFfHqFb-4ur6eTG6x5ygUuqc4ZEZoVFJSgOa1rBRmnRcWrKi_HipQFKZjWHZLVRalSACFICUxUZZpn_DT5tPddt-UKKg2uG8XKdWNWqtlKr4x8jDizlAv_IDOS0aKTk71cdwsLDdRHJSWyL1r2RcuxkIzLXdGd5O3fiX8E-2Y7_P0BV0ErW3eb0SYcaWnGRJbnHe3dgdYH_EYfB334P0PWrbURNrGjvtlT70P0zZHLeE7yIuW_APZs2WQ</recordid><startdate>19921201</startdate><enddate>19921201</enddate><creator>von Hofe, Eric</creator><creator>Fairbairn, Leslie</creator><creator>Margison, Geoffrey P.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>19921201</creationdate><title>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</title><author>von Hofe, Eric ; Fairbairn, Leslie ; Margison, Geoffrey P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3439-b1c6209c271ea9161ffae5317d3dd6b8a0b7072cc61f5f7ba4ee990be29db4653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Cell culture techniques</topic><topic>Cell Cycle</topic><topic>Cell lines</topic><topic>Cell Survival - drug effects</topic><topic>Cell Transformation, Neoplastic - drug effects</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Chemical agents</topic><topic>Cytotoxicity</topic><topic>DNA Damage</topic><topic>DNA Repair</topic><topic>Doubling time</topic><topic>Genes</topic><topic>Genetic mutation</topic><topic>In Vitro Techniques</topic><topic>Lesions</topic><topic>Medical sciences</topic><topic>Methylnitronitrosoguanidine - pharmacology</topic><topic>Methyltransferases - genetics</topic><topic>Methyltransferases - metabolism</topic><topic>Mice</topic><topic>Mutagenesis</topic><topic>O-Methylguanine-DNA Methyltransferase</topic><topic>Transfection</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>von Hofe, Eric</creatorcontrib><creatorcontrib>Fairbairn, Leslie</creatorcontrib><creatorcontrib>Margison, Geoffrey P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>von Hofe, Eric</au><au>Fairbairn, Leslie</au><au>Margison, Geoffrey P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1992-12-01</date><risdate>1992</risdate><volume>89</volume><issue>23</issue><spage>11199</spage><epage>11203</epage><pages>11199-11203</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><coden>PNASA6</coden><abstract>While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.</abstract><cop>Washington, DC</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>1454799</pmid><doi>10.1073/pnas.89.23.11199</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11199-11203 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_jstor_primary_2360674 |
source | Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Animals Biological and medical sciences Carcinogenesis Carcinogenesis, carcinogens and anticarcinogens Cell culture techniques Cell Cycle Cell lines Cell Survival - drug effects Cell Transformation, Neoplastic - drug effects Cells Cells, Cultured Chemical agents Cytotoxicity DNA Damage DNA Repair Doubling time Genes Genetic mutation In Vitro Techniques Lesions Medical sciences Methylnitronitrosoguanidine - pharmacology Methyltransferases - genetics Methyltransferases - metabolism Mice Mutagenesis O-Methylguanine-DNA Methyltransferase Transfection Tumors |
title | Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A36%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20Between%20O6-Alkylguanine-DNA%20Alkyltransferase%20Activity%20and%20N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced%20Mutation,%20Transformation,%20and%20Cytotoxicity%20in%20C3H/10T1/2%20Cells%20Expressing%20Exogenous%20Alkyltransferase%20Genes&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=von%20Hofe,%20Eric&rft.date=1992-12-01&rft.volume=89&rft.issue=23&rft.spage=11199&rft.epage=11203&rft.pages=11199-11203&rft.issn=0027-8424&rft.eissn=1091-6490&rft.coden=PNASA6&rft_id=info:doi/10.1073/pnas.89.23.11199&rft_dat=%3Cjstor_cross%3E2360674%3C/jstor_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1454799&rft_jstor_id=2360674&rfr_iscdi=true |